Button to scroll to the top of the page.

Updates

News

From the College of Natural Sciences
New Sensor May Soon Test for Coronavirus and Flu Simultaneously

New Sensor May Soon Test for Coronavirus and Flu Simultaneously

The novel coronavirus has been compared to the flu almost from the moment it emerged in late 2019. They share a variety of symptoms, and in many cases, an influenza test is part of the process for diagnosing COVID-19.

Cancer Drug with Better Staying Power and Reduced Toxicity Shows Preclinical Promise

Cancer Drug with Better Staying Power and Reduced Toxicity Shows Preclinical Promise

The drug candidate, called OxaliTEX, is made of two parts: a star-shaped molecule (blue) called texaphyrin that acts like a kind of delivery truck and a modified version of a platinum drug (red) that acts like a toxic package for cancer cells. Illustration credit: iQ Group Global.

​A drug candidate has been found in preclinical trials to stop tumor growth entirely, deliver more cancer-busting power than many commonly used chemotherapy drugs and do so with fewer toxic side effects and more ability to overcome resistance.

Breakthrough in Coronavirus Research Results in New Map to Support Vaccine Design

Breakthrough in Coronavirus Research Results in New Map to Support Vaccine Design

Researchers from The University of Texas at Austin and the National Institutes of Health have made a critical breakthrough toward developing a vaccine for the 2019 novel coronavirus by creating the first 3D atomic scale map of the part of the virus that attaches to and infects human cells.

An Experimental Anti-Cancer Drug Has an Unexpected Method of Attacking Cancer

An Experimental Anti-Cancer Drug Has an Unexpected Method of Attacking Cancer

Researchers were surprised to find that BET inhibitors have a second mechanism of attacking cancer cells, namely damaging the cell's DNA. Credit: iStock.

A widely used class of chemotherapy drugs, called topoisomerase inhibitors, come with some serious downsides: bone marrow damage, reduced blood cell production, diarrhea and heart damage. And some cancers can quickly develop resistance. A new discovery about a second class of drugs might lead to combination therapies that are just as effective, but with fewer downsides.

Kami Hull Seeks to Make Drugs Faster with Less Waste

Kami Hull Seeks to Make Drugs Faster with Less Waste

New faculty in Natural Sciences conduct compelling research and inspire new generations, right out of the gate. As the 2019-20 academic year begins, we are introducing faculty members whose compelling work is worth learning about. Here meet Kami Hull. Within months of joining the faculty, she won a prestigious Novartis Early Career Award in Chemistry in recognition of her research, which involves developing more efficient processes for synthetic organic chemistry.

New Drug Has Potential to Protect Brain Cells from Traumatic Injuries

New Drug Has Potential to Protect Brain Cells from Traumatic Injuries

Traumatic brain injuries (TBIs), caused by everything from falls to being hit by moving objects to car crashes, cause nearly a third of all injury-related deaths in the U.S. Millions of survivors struggle with impaired thinking and movement, personality changes or depression.

HIV Hidden in Patients’ Cells Can Now Be Accurately Measured

HIV Hidden in Patients’ Cells Can Now Be Accurately Measured

This human T cell (blue) is under attack by HIV (yellow), the virus that causes AIDS. The virus specifically targets T cells, which play a critical role in the body's immune response against invaders like bacteria and viruses. Credit: Seth Pincus, Elizabeth Fischer and Austin Athman, National Institute of Allergy and Infectious Diseases, National Institutes of Health.

Until now, researchers haven't been able to accurately quantify a latent form of HIV that persists in patients' immune cells. This hampers doctors' ability to assess the effectiveness of a particular treatment and select better alternatives.

UT Austin Chemist Livia Eberlin Named a Moore Inventor Fellow

UT Austin Chemist Livia Eberlin Named a Moore Inventor Fellow

Livia Eberlin has been named a Moore Inventor Fellow. Photo courtesy of Moore Foundation.

A foundation that has set a goal this decade of identifying 50 inventors who will shape the next 50 years has added its second University of Texas at Austin faculty member to the list. The Gordon and Betty Moore Foundation announced Livia Eberlin, assistant professor in the Department of Chemistry, is one of this year's five Moore Inventor fellows.

New Flu Drug Informed by UT Austin Professor's 40-year-old Basic Research

New Flu Drug Informed by UT Austin Professor's 40-year-old Basic Research

Last year, Texas saw a particularly deadly flu season. Now, there is a new Federal Drug Administration-approved treatment, Xofluza, designed to catch the flu in its early stages and stop it from spreading. The drug is thanks in large part to professor emeritus Robert Krug's basic research, undertaken almost 40 years ago.

New Protein Sequencing Method Could Transform Biological Research

New Protein Sequencing Method Could Transform Biological Research

An ultra-sensitive new method for identifying the series of amino acids in individual proteins (a.k.a. protein sequencing) can accelerate research on biomarkers for cancer and other diseases. Credit: David Steadman/University of Texas at Austin.

A team of researchers at The University of Texas at Austin has demonstrated a new way to sequence proteins that is much more sensitive than existing technology, identifying individual protein molecules rather than requiring millions of molecules at a time. The advance could have a major impact in biomedical research, making it easier to reveal new biomarkers for the diagnosis of cancer and other diseases, as well as enhance our understanding of how healthy cells function.